Serabi Gold has reduced its 2026 gold production guidance to match 2025 levels, citing delays in obtaining necessary permits for its Coringa mine. The company now expects to produce around 44,169 ounces in 2026, down from the previous forecast of over 53,000 ounces. The delay stems from pending approvals required to transport additional ore to the Palito processing plant, including land use changes and Indigenous study sign-offs. Despite these setbacks, Serabi maintains a strong cash position of $63.2 million and plans to increase processing capacity in 2027 with lower capital expenditure.
Serabi Gold shares and related market context are shown here as of Oct 21, 2026 16:02 WIB. For readers following US stocks on Pluang, 66 out of 150 priced stocks rose while 78 fell today. Notable movers include SPCE at USD 2.42 with a 1-day change of +2.11% and Pluang order activity of 86% Sell / 14% Buy, JD at USD 26.20 down 2.09% with 0% Sell / 100% Buy, and ACN at USD 234.16 down 2.07% with 98% Sell / 2% Buy. The most notable figure is SPCE's 86% sell order activity.
The Human Feedback Foundation, supported by RBC, has launched the Agentic AI Design Exchange, a national program aimed at helping Canadian nonprofits design, build, and deploy AI agents responsibly. Funded through RBC's Stronger Nonprofits Program, t...
Satellos Bioscience Inc., a clinical-stage company focused on treatments for degenerative muscle diseases, announced its management will participate in two investor conferences in November: the Guggenheim Healthcare Innovation Conference on Nov 9 in ...
YYForce Inc. has purchased 20 wearable data collection systems to gather real task data from hotel room service at Novotel Singapore. This project aims to record and analyze experienced staff performing tasks like bed-making, towel folding, and clean...
The global digital health and remote patient monitoring market is projected to grow from $26.8 billion in 2025 to $80.8 billion by 2031, at a compound annual growth rate of 20.2%. This growth is driven by increasing demand for chronic disease managem...
The global private credit and alternative lending market, valued at $2.31 trillion in 2026, is expected to grow at a 7.8% CAGR to reach $3.36 trillion by 2031. Recent liquidity pressures in 2025, triggered by bankruptcies and AI sector concerns, caus...
